<html><head><title>Berndt Höppner type</title>
<meta http-equiv="Content-Type" content="text/html">
<meta http-equiv="Author" name="Berndt Höppner" content="type">
<meta http-equiv="Author" name="type" content="type">
<meta name="Language" content="de-en">
<meta name="Keywords" lang="de" content="type, Berndt Höppner, type">
<meta name="Keywords" lang="en" content="Berndt Höppner, type, , type">
<meta name="Description" lang="al "content=" Bei ihnen kann gezielt nach der Mutation des Index-Patienten gesucht werden. A RET double mutation in the germline of a kindred with FMTC. A new hot spot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A, J. Evidence for calcitonin - a new hormone from the parathyroid that lowers blood calcium. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.">
<meta name="Revisit-after" content="1 month">
<meta name="Date_modified" content="2001-06-13">
<meta name="ROBOTS" content="index,follow">
</head>
<style type="text/css"> 
	A.nav:link {TEXT-DECORATION: none}
	A.nav:visited {TEXT-DECORATION: none} 
	A.nav:visited {TEXT-DECORATION: none}
	A.nav:active {TEXT-DECORATION: none}
	A.nav:hover {TEXT-DECORATION: none}
	</style><body bgcolor="#FFFFF">
	<font face="arial" size="3" color="#000000">
	<table border="0" cellpadding="0" cellspacing="0" width="100%">
	<tr><td><a href="type.html" class="nav">type</a></td></tr>
	<tr><td><a href="index.html" class="nav">home page</a></td></tr></table>
	<br><div align="center"><font size="6">- type -<br><br></font></div>
<table width="100%" border="0" cellspacing="2" cellpadding="3">
<td valign="bottom"><img height="238" width="150" src="http://www.brinkmann-literatur.de/LitMag36.jpg"></td>
<td valign="center">
 Das initial mit seinem Namen benannte Syndrom wird heute als Multiple Endokrine Neoplasie Typ 1 bezeichnet. Bei Nachweis der MEN2B-Mutation ist aufgrund des aggressiven Verlaufs die Operation bereits im 1. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Menin mutations in patients with multiple endocrine neoplasia type 1. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="4">
<td valign="top"><img HEIGHT="104" WIDTH="104" src="http://www.uke.uni-hamburg.de/forschung/grk336/Forschung//images/siegel-forschung.gif"></td>
<td valign="center">
 The structural consequences of the LE mutations are discussed in relation to the 3-dimensional structure of LE-domains. . Mutations in USH2A, located on 1q41 were recently shown to be responsible for Usher type IIa. The USH2A gene encodes a protein of 1546 amino acids that contains laminin type epidermal growth factor (LE)- and fibronectin type III like motifs. Mutations were detected by PCR-based exon amplification and direct, automated DNA sequencing.</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="1" cellpadding="3">
<td valign="bottom">
 Bei ihnen kann gezielt nach der Mutation des Index-Patienten gesucht werden. A RET double mutation in the germline of a kindred with FMTC. A new hot spot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A, J. Evidence for calcitonin - a new hormone from the parathyroid that lowers blood calcium. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="2" cellpadding="0"
<td valign="bottom">
 In contrast to these rare events, heterozygous missense mutations in exon 13, codons 790 and 791, were found in 5 families (4 with MTC only; 1 family with MTC and pheochromocytoma) and 11 patients with apparently sporadic tumors. . A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. One hundred and eighty-one families with multiple endocrine neoplasia type 2A (MEN-2A) or familial medullary thyroid carcinoma (FMTC) have been investigated for mutations in the ret protooncogene in Germany. In 8 families with FMTC or MEN-2A, no mutation could be detected in the cysteine-rich domain encoded in exons 10 and 11 of the ret protooncogene.</td>
<tr>
</table>
<br>further information: <a href="http://www.blackwell-synergy.com/Journals/member/processpaid.asp?contentid=eci.2000.5&filetype=articles&article=56237&year=&journal=">http://www.blackwell-synergy.com/Journals/member/processpaid.asp?contentid=eci.2000.5&filetype=articles&article=56237&year=&journal=</a><br><br>
</font><font size=-6> <a class="nav" href="http://www.krungkuene.org/~werner/125/index.html">.</a><br><br>
</font></body></html>
